M37-24827-68989 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-16
Registered in v-safe
2021-03-16
Dose 1 — Janssen/Johnson & Johnson
2021-03-16
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-17
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-03-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-14
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2021-10-25
Dose 2 — Moderna
2021-10-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-10-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-08
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-17
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-11-22
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-11-29
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2022-01-26
Survey response — 3 months, dose 2
MedDRA: Back pain, Chest discomfort, Myalgia, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Congestion, runny nose, chest tightness, back pain, muscle aches

MedDRA releases: 2024-11 · check-in free text available
2022-04-25
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-16	Janssen/Johnson & Johnson
2	2021-10-25	Moderna	No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 11 — 3 months, dose 2

2022-01-26

Symptoms: Congestion, runny nose, chest tightness, back pain, muscle aches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Back pain	·	·	✓
SD	Chest discomfort	·	·	✓
SD	Myalgia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release